Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026)

Adaptin Bio has disclosed Accumulated Expenses across 3 years of filings, most recently posting $810589.0 for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 55.39% year-over-year to $810589.0; the TTM figure through Jun 2026 stood at $810589.0 (up 55.39% YoY), while the FY2025 annual figure was $596465.0, down 43.19% from the prior year.
• Accumulated Expenses came in at $810589.0 for Q2 2026 at Adaptin Bio, down from $869681.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.0 million in Q4 2024 to a low of $521656.0 in Q2 2025.
• Average Accumulated Expenses over 3 years is $736065.7, with a median of $781683.0 recorded in 2025.
• Year-over-year, Accumulated Expenses tumbled 43.19% in 2025 and surged 55.39% in 2026.
• Over 3 years, Accumulated Expenses stood at $1.0 million in 2024, then plunged by 43.19% to $596465.0 in 2025, then soared by 35.9% to $810589.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $810589.0 in Q2 2026, $869681.0 in Q1 2026, and $596465.0 in Q4 2025.